Multi-Modality Imaging Standard Cohort Of Cerebrovascular Disease

Recruiting now

Conditions studied: Cerebrovascular Disease

In brief

The aim of this study is to establish a multi-center and multi-modality imaging standard cohort of cerebrovascular disease, analyze the potential mechanisms affecting the prognosis of cerebrovascular disease based on a variety of imaging methods, and explore potential therapeutic targets.

Key facts

Study ID

NCT06925178

Run by

Beijing Tiantan Hospital

People needed

800

Starts

2025-01-01

Expected to finish

2027-09-30

Last updated by the study team

2025-04-13

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Age between 18 and 80 years old;
• Onset of symptoms within 7 days;
• Clinical diagnosis of cerebrovascular disease (ischemic stroke or hemorrhagic stroke) confirmed by head imaging (CT or MRI);
• Signed informed consent form.

You may not qualify if…

• Diagnosed with non-cerebrovascular diseases (such as central nervous system infections, epilepsy, and metabolic encephalopathy);
• Patients with contraindications to multimodal CT or MRI, functional near-infrared imaging, or those who cannot cooperate to complete the relevant examinations;
• Patients with a life expectancy of less than 3 months or those who cannot complete the study follow-up due to other reasons.

Where it is running

• Beijing Tiantan Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.